1 - 3 June, 2027
Congress CenterBasel SwitzerlandDr. Gregory Segala, PhDChief Scientific Officer at FluoSphera SASpeaker
Profile
Gregory Segala, PhD, is co-founder and Chief Scientific Officer of FluoSphera. He co-invented FluoSphera’s tissue multiplexing technology, which combines multiple 3D microtissues in a single well, and led the development of an assay to assess ADC-associated lung toxicity, particularly interstitial lung disease. His technology platform focuses on improving preclinical decision-making by identifying potential safety liabilities before clinical development
Agenda Sessions
Early Identification of Interstitial Lung Disease Risk While Measuring ADC Efficacy in a Human Systemic In Vitro Platform
, 11:30View Session